| Name | Title | Contact Details |
|---|
Jackson Healthcare is built on a simple idea — that talented professionals with a shared purpose can improve the lives of patients, families and communities. Headquartered in Alpharetta, Georgia, the company has risen to a place of prominence among the largest healthcare staffing and technology companies in the U.S. It currently serves more than seven million patients in over 1,300 healthcare facilities. In addition to serving health systems and providers, Jackson champions local, national and international charitable work. It founded and sponsors the Hospital Charitable Service Awards, which honors programs that set new standards for health and wellness in their communities through education, access and delivery. Atlanta Business Chronicle named Jackson Healthcare the city’s “Best Place to Work” in 2014, 2015, and 2016 and “Healthiest Large Company” in 2015.
Gillette Children's Specialty Health is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Gillette Children's Specialty Health is based in Saint Paul, MN. You can find more information on Gillette Children's Specialty Health at www.gillettechildrens.com
Affinity Health & Wellness is a medical marijuana dispensary located in New Haven, CT that aims to create a relationship with each patient built on compassion, trust and optimal outcomes.
Mesa Plms Retirement Cmnty is a Mesa, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aimmune is a clinical-stage biopharmaceutical company advancing a new therapeutic approach, including the development of proprietary product candidates, for the treatment of peanut and other food allergies. Our mission is to improve the lives of people with food allergies by developing and commercializing proprietary desensitization therapies that safely and reliably protect them from accidental exposure to food allergens. We aim to address food allergies by providing a treatment option that goes beyond the current protocols of avoiding exposure to food allergens and carrying epinephrine for administration in case of accidental exposure. Our CODIT™ system is based on extensive independent scientific research demonstrating that most patients with food allergies can become desensitized to the allergens, or proteins, in a particular food through the oral administration of gradually increasing amounts of the allergens. In oral immunotherapy (OIT), a very small amount of an allergen is administered on a daily basis and then regularly increased until desensitization to a certain amount of the allergen has been achieved. We plan to develop and commercialize standardized, pharmaceutical-grade food allergens for our CODIT™ (characterized oral desensitization immunotherapy) system, our system for OIT. Our lead product candidate, AR101, is a standardized, complex mixture of 13 naturally occurring proteins and pharmaceutical-grade ingredients that, with the CODIT system of gradual, controlled updosing and ongoing maintenance dosing, has obtained meaningful desensitization to peanut allergens in our initial clinical studies.